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ABSTRACT
Human toxocariasis consists of chronic tissue parasitosis that is difficult to treat and 
control. This study aimed to evaluate the action of the probiotic Lactobacillus acidophilus 
ATCC 4356 on larvae of Toxocara canis and the effect of IFN-γ cytokine on parasite-host 
in vivo (1.109 CFU) and in vitro (1.106, 1.107, 1.108, 1.109 CFU) interactions. Four groups of 
six BALB/c mice were formed: G1 - L. acidophilus supplementation and T. canis infection; 
G2 - T. canis infection; G3 - L. acidophilus supplementation; and G4 - PBS administration. 
Mice were intragastrically suplemented with probiotics for 15 days before inoculation and 
48 h after inoculation with 100 T. canis eggs. The inoculation of T. canis was also perfomed 
intragastrically. The recovery of larvae took place through digestion of liver and lung tissues; 
the evaluation of IFN-γ gene transcription in leukocytes was performed by qPCR. The in 
vitro test consisted of incubating the probiotic with T. canis larvae. The supplementation of 
probiotics produced a reduction of 57.7% (p = 0.025) in the intensity of infection of T. canis 
larvae in mice, whereas in the in vitro test, there was no larvicidal effect. In addition, a decrease 
in the IFN-γ gene transcription was observed in both, T. canis-infected and uninfected mice, 
regardless of whether or not they received supplementation. The probiotic L. acidophilus 
ATCC 4356 reduced T. canis infection intensity in mice, however, the probiotic did not have 
a direct effect on larvae, demonstrating the need of interaction with the host for the beneficial 
effect of the probiotic to occur. Yet, the proinflammatory cytokine IFN-γ did not apparently 
contributed to the observed beneficial effect of probiotics. 
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INTRODUCTION
Human toxocariasis involves chronic tissue parasitosis, is globally distributed 
and is most prevalent in countries with tropical climate1. The main etiological agents 
are the nematodes Toxocara canis and Toxocara cati, intestinal parasites of dogs and 
cats, respectively. In humans, larvae of these nematodes are incapable of reaching 
maturity they undergo tissue migration affecting various organs and causing lesions 
of varied degrees of severity. The main form of infection in humans is through 
the ingestion of embryonic eggs of the parasite, but it can also occur through the 
ingestion of larvae present in meat or viscera of paratenic hosts, ingested raw or 
undercooked2,3. This parasitosis is considered a neglected disease that is prevalent 
in some developed4 and developing countries5.
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In the host immune response triggered by T. canis, 
the parasite switches the Th1 to Th2-type response6. 
Studies using murine models have shown that in the early 
phase of T. canis infection, there is an increase in IFN-γ, 
TNF-α and IL-12 cytokine levels7,8. During infection, 
T. canis modulates the immune response by suppressing 
proinflammatory cytokines production and stimulating 
the production of cytokines by Th2 and Treg cells6,9. This 
modulation is a form of parasite evasion from the host 
immune response as proinflammatory cytokines, such as 
IFN-γ and IL-12, are important macrophages activators that 
act in the defense against the nematode8,10-12.
Human toxocariasis is a parasitosis that is difficult 
to treat due to the moderate effectiveness of drugs on 
the encysted larvae of Toxocara spp. in tissues, making 
it necessary to investigate other forms of control13-15. 
An alternative treatment is the use of probiotics, which 
have demonstrated potential to control murine visceral 
toxocariasis16-20. One of the modes of action of probiotics 
is through their capacity to counterbalance the Th1-, Th2- 
and Treg-type immune responses21 and by their ability 
to inhibit the adhesion of pathogenic microorganisms 
to the intestinal epithelium through the production of 
antimicrobial substances such as short chain fatty acids, 
ammonia, hydrogen peroxide and bacteriocins22.
Probiotics of the genus Lactobacillus contribute 
to reduce the luminal pH by stimulating the growth of 
epithelial cells and increasing the blood flow, modifying the 
intestinal motility, improving the absorption of water and 
minerals and increasing mucus production23. In addition, in 
vivo studies with Lactobacillus spp. have shown that these 
probiotics are capable of stimulating the Th1-type immune 
response, with increased IFN-γ, IL-12 and TNF-α cytokines 
production24-29, which may also be beneficial for the control 
of visceral toxocariasis8. This study aimed to evaluate 
the action of the probiotic Lactobacillus acidophilus 
ATCC 4356 on the infection intensity of T. canis in BALB/c 
mice and the effect of the proinflammatory cytokine IFN-γ 
on the parasite-host interactions.
MATERIALS AND METHODS
Mice
Male BALB/c mice of five to seven weeks of age were 
maintained under controlled environmental conditions 
at 22 °C (± 1 °C), with a 12 h light and 12 h dark cycle, 
and access to food and water ad libitum. This project 
was approved by the Animal Use Ethics Committee 
of the Federal University of Rio Grande (P039/2016, 
P078/2016).
Probiotic Lactobacillus acidophilus
The probiotic L. acidophilus ATCC 4356 obtained from 
the Fundacao Oswaldo Cruz in Rio de Janeiro/RJ - Brazil 
(FIOCRUZ) was cultivated in Man, Rogosa and Sharpe 
(MRS) broth for 48 h at 37 °C. It was then centrifuged at 
4000 x g for 10 min and resuspended in sterile phosphate-
buffered saline (PBS). Next, the colony-forming units 
(CFU) were determined. Probiotic production, quality 
control, culture viability, colony counts and purity were 
evaluated according to the methodology employed by 
Walcher et al.20.
Collection and incubation of the eggs and larvae of 
Toxocara canis
Five to eight weeks-old dogs naturally infected 
with T. canis were treated orally with pyrantel pamoate 
(15 mg/kg) to recover adult specimens of T. canis. The 
adult forms of T. canis were sexed and the females were 
submitted to hysterectomy to obtain eggs, which were 
incubated in 2% formalin at 28 °C, with humidity greater 
than 80% and oxygenation for 30 days19. Following the 
eggs embryonation, T. canis larvae were extracted and 
incubated12,30.
In vitro evaluation of the probiotic Lactobacillus 
acidophilus
The probiotic L. acidophilus was tested at concentrations 
of 1.106, 1.107, 1.108 and 1.109 CFU and incubated at 
concentrations of 100 larvae/well (microculture plate 
TPP®) in RPMI-1640 medium supplemented with 25 mM 
HEPES, 1% glucose, 100 IU/mL penicillin, and 50 μg/mL 
streptomycin) at 37 °C with 5% CO
2
 for 48 h, in triplicate31.
After the plate incubation, 0.2% Trypan blue cell 
viability indicator (Vetec®) was added to all wells in the 
plate, and the material was incubated for an additional 
30 min. Control RPMI-1640 medium with live T. canis 
larvae and control dead larvae (frozen at -20 °C/ 10 days, 
followed by heat shock at 60 °C) were also used. The 
viability evaluation was based on the following criteria: 
morphological integrity, motility and absence of Trypan 
blue staining. The evaluation was performed using an 
optical microscope at 100 x and 400 x magnification.
In vivo evaluation of the infection intensity
Four groups of six BALB/c mice were formed: G1 – 
mice were supplemented with the probiotic (1.109 CFU) 
intragastrically (IG) for 15 days before the inoculation of 
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100 T. canis eggs (IG), and the supplementation condinued 
for 2 days post-inoculation (P.I); G2 – IG administered with 
sterile PBS, for 15 days preinoculation and 48 h post-IG 
inoculation of 100 T. canis eggs; G3 – IG supplemented 
with probiotic for 17 days; and G4 – IG-administered sterile 
PBS for 17 days20. Mice were euthanized 2 days P.I and the 
experiment lasted 17 days. Euthanasia was perfomed with 
thiopental by intraperitoneal injections (75 mg/kg). Next, 
the digestion of the liver and lung tissues from animals of 
groups G1 and G2 was performed in 1% pepsin solution 
and 1% hydrochloric acid with constant shaking overnight 
at 37 °C32. Afterwards, T. canis larvae were recovered 
and quantified by optical microscopy at 100 x and 400 x 
magnification.
IFN-γ gene transcription
Whole-blood samples were obtained from the mice 
belonging to the four groups (G1, G2, G3, and G4) on the 
day of euthanasia using a pool of blood samples per group. 
Leukocytes were isolated from whole blood samples after 
cell lysis to eliminate red blood cells followed by washingin 
Hanks solution and storage in TRI Reagent® (Sigma Aldrich) 
at -70 °C. Subsequently, RNA extraction and cDNA 
synthesis were performed using a High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, Foster City, 
CA, USA) as instructed by the manufacturer. Quantitative 
polymerase chain reactions (qPCRs) were performed in a 
Step One Plus apparatus (Applied Biosystems, Foster City, 
CA, USA) using specific primers for IFN-γ and GAPDH, the 
latter was included as a reference gene8. The qPCRs were 
performed with 1 μL of cDNA (synthesized from 300 ng/μL 
of RNA), 6.25 μL of Go Taq® qPCR Master Mix (Promega 
Corporation, Madison, Wisconsin, USA), 0.5 μM of each 
primer and 4.25 μL of RNAse-free water (Sigma Aldrich, 
Brasil Ltda) in a final volume of 12.5 μL. The temperatures 
used were as follows: an initial denaturation at 95 °C for 
5 min, followed by 40 cycles of denaturation at 95 °C for 
30 s, annealing at 60 °C for 60 s, extension at 72 °C for 60 s 
and a final extension step at 72 °C for 5 min. All samples 
were tested in duplicate. The cycle threshold (Ct) values were 
used to calculate the variation in gene expression relative to 
GAPDH (control) expression.
Statistical analysis
Data regarding the infection intensity by T. canis and the 
IFN-γ gene transcription were compared by the Student’s 
t-test, with a significance level of 0.05 (BioEstat version 
5.0, AnalystSoft Inc., Walnut, CA, USA). The viability 
of T. canis larvae (in vitro test) was evaluated by analysis 
of variance (ANOVA), and the means were compared by 
Tukey’s test, with a significance level of 0.05 (BioEstat 
version 5.0, AnalystSoft Inc., Walnut, CA, USA).
RESULTS
Compared to control mice (G2), animals supplemented 
with the probiotic L. acidophilus ATCC 4356 (G1) presented 
a 57.7% (p=0.025) reduction in the total number of larvae 
recovered from the liver (Table 1). Larval positivity in the 
liver was observed in all G1 and G2 mice, confirming the 
acute T. canis infection. No larvae were recovered from 
the lungs.
In the in vitro test, compared to the control, the different 
concentrations of L. acidophilus probiotic had no direct effect 
on T. canis larvae during the 48 h incubation period with 
T. canis larvae (p > 0.05). The mean percentage of larvae 
with morphological integrity, positive motility and no Trypan 
blue staining ranged from 93.8% to 95.3%. These means 
were similar to those of the control live larvae, of 94.6%. In 
the control group of dead larvae, all larvae were not viable, 
that is, they showed no motility and Trypan blue staining.
IFN-γ gene transcription
Compared to that in control mice supplemented with 
PBS (G4), IFN-γ gene transcription was reduced by three 
times in mice supplemented with probiotics and infected 
with T. canis (G1) and six times in mice supplemented with 
probiotics (G3). IFN-γ gene expression in mice infected with 
only T. canis (G2) was not significantly different from that 
of mice in the PBS control group (G4; Figure 1). After 48 h 
of T. canis egg inoculation, mice without supplementation 
had consistent IFN-γ (G2) gene transcription levels.
DISCUSSION
Several studies have already shown the potential of 
different Lactobacillus species probiotics to prevent and 
Table 1 - Mean number of Toxocara canis larvae recovered 
from the liver 48 h post inoculation of 100 embryonated eggs 
in BALB/c mice supplemented with the probiotic Lactobacillus 
acidophilus (1.109 CFU; n = six mice/group).
Groups
Mean (± standard 
deviation)
p
Control 5.2 (± 2.16)
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treat parasitosis, such as Trichinella spiralis, Giardia lamblia 
and Toxocara canis20,33-35. The results obtained in this study 
have shown that supplementation with L. acidophilus ATCC 
4356 has significantly reduced the infection intensity of 
Toxocara canis larvae in experimentally infected mice. The 
rate of reduction in the intensity of infection induced by this 
probiotic was similar to that observed by Walcher et al.20, 
who used the probiotic L. rhamnosus ATCC 7469 (53.3%). 
These results confirm the potential of Lactobacillus spp. to 
control toxocariasis under the tested conditions. 
Despite the in vivo action of L. acidophilus ATCC 4356 
on reducing the infection intensity, no in vitro direct effect 
on T. canis larvae was observed. Similar results have been 
shown with the probiotics S. boulardii31 and L. rhamnosus 
ATCC 435620, which reduced the intensity of infection in 
mice and showed no in vitro effect on the larvae. In addition, 
our results are corroborated by those of other studies 
suggesting that the interaction between S. boulardii and the 
intestinal mucosa of T. canis-infected mice is necessary for 
the development of the beneficial effect of this probiotic31,36.
To understand the mechanism underlying the action 
of this probiotic, the IFN-γ gene transcription was 
evaluated, as this is an important cytokine involved in the 
recruitment of macrophages during the acute phase of 
toxocariasis10. However, in this study, mice supplemented 
with L. acidophilus ATCC 4356, both infected and 
uninfected, had reduced IFN-γ gene transcription levels, 
similar to those of mice supplemented with L. casei 
ATCC 7469 and infected with Trichinella spiralis33. 
According to these authors, IFN-γ gene transcription levels 
were reduced in comparison with those of the control as 
IFN-γ production was poorly induced due to the small 
number of infective larvae, and the same phenomenon may 
have occurred in this study. However, animals supplemented 
with other species of Lactobacillus have shown increased 
levels of this proinflammatory cytokine25,27,29, indicating 
that the effect obtained with one species of microorganism 
used as a probiotic cannot be extrapolated to other species, 
since closely related species can produce distinct effects 
or even opposite effects. Therefore, it is important that 
probiotics are characterized at the strain level37.
Other hypotheses that may explain the variation in the 
results of different studies that evaluated the protective 
effect of probiotics against T. canis infections include the 
use of different probiotics (Enterococcus faecalis CECT 
7121, S. boulardii and L. rhamnosus ATCC 7469), the dose 
of the administered probiotic, the species and lineage of the 
host and the evaluated organ8,17-20,36.
Although no increment in the transcription of IFN-γ 
was observed in animals supplemented with L. acidophilus, 
the obtained results suggest that the effect of this probiotic 
against T. canis involves the innate immunity participation, 
as the reduction in the number of larvae occurred within 
48 h, an insufficient period for the development of an 
adaptive immune response8,10. In addition, in this study, 
IFN-γ transcription levels were evaluated at the systemic 
level (blood) and the action of the probiotic can occur at 
the local level (intestinal mucosa)36, and this aspect, like 
other pro-inflammatory and anti-inflammatory interleukins 
need to be evaluated in future studies. 
CONCLUSION
The probiotic Lactobacillus acidophilus ATCC 4356 
reduced the intensity of T. canis infection. However, the 
proinflammatory cytokine IFN-γ was not involved in this 
reduction and in the establishment of infection by T. canis 
larvae, and the probiotic did not have a direct effect on 
larvae, demonstrating the need of the interaction with the 
host for the probiotic beneficial effect to occur. Thus, it is 
important to evaluate other possible mechanisms of action 
of the probiotic, as well as other cytokines, to elucidate its 
protective effect.
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